Regenxbio is a biotechnology company based in Rockville, MD, specializing in the development of gene therapies for a variety of genetic disorders. Their innovative approach focuses on utilizing adeno-associated virus (AAV) vectors to deliver therapeutic genes to target cells.
With a commitment to advancing gene therapy research and development, Regenxbio collaborates with academic institutions and industry partners to bring potential treatments to patients in need. Their work aims to address unmet medical needs and improve the lives of individuals affected by genetic diseases.
Generated from their business information